Results

Total Results: 1,540 records

Showing results for "month".

61. Cer-250-Cannabis-Table-E5-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-table-e5-2022-update_0.xlsx
    January 01, 2022 - B Mean mg/week at 3 month followup THC: 93.29 (SD 228.12) vs. … least 3 months NR 433 A: 55 B: 65 C: 313 A: Daily or weekly use of marijuana B: Monthly or 1-2 times a month … B Mean mg IV morphine (SD) 12.4 (20.1) vs. 12.3 (12.4); patient-month level trend analysis -0.64 (95%

62. Lumbar-Fusion-Draft-Report-Appendix-D (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-draft-report-appendix-d.xlsx
    January 01, 2019 - B Serious AEs: 0% vs. 0% NR NR Industry University High 1 month 12 months PGIC 9367 5 (RFA) Duger, … B Any AE: 0% vs. 0% NR NR NR High 1 day 2 days 1 week 2 weeks 1 month 12 months Patient satisfaction … Government Low 1 month Global Perceived Effect (marked or very marked improvement overall [score of 1 … B Median 42 vs. 44 47% NR NR Previous spinal surgery: 12% 1 month (AEs), 3 months  A vs. … B Serious complications, % (n/N) 1 month 0% (0/44) vs. 0% (0/42), RR NA Adverse events, % (n/N) 1 month

63. Executive Summary_Comparative Effectiveness Review No. 252: Management of Infantile Epilepsies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-executive-summary.pdf
    October 01, 2022 - These criteria focused on studies enrolling infants with epilepsy age 1 month to <36 months; we excluded … and Limitations Strengths of the review include an exhaustive search for any evidence on infants 1 month

64. Disposition of Comments for Comparative Effectiveness Review 133 Transitional Care Interventions To Prevent Readmissions for People With Heart Failure (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-failure-transition-care_disposition-comments.pdf
    May 27, 2014 - E.g. if a study provided data for 1, 3 and 6 month…only use the 6 month data. … Thank you, we have collapsed the 3 and 6- month outcome timings. … a 6 month outcome from another study the # of events is likely greater in a 6 month vs. a 3 month study … As above, we have combined the 3 and 6-month outcome timings. … However, the same Naylor study was used for the 30 day 3 month and six month outcomes and contributed

65. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
    January 01, 2016 - Reported costs of Bydureon from 11 U.S. pharmacies range from $354 to $469 per month or about $4,250 … The incidence of incisional glaucoma surgery at month 36 was 4.8% in the low- dose group and 8.1% in … The mean improvement in BCVA letter score between baseline and month 24 was 4.4 and 5.4 in the low- … This 24-month data is the data that was submitted in the manufacturer’s original 2010 FDA new drug … The 36-month trial results were provided to FDA in May 2011.

66. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
    November 03, 2011 - Foundation defines chronic migraine as headache, tension-type or migraine, that occurs >15 days per month … guidelines recommend preventive treatments for patients who have five or more migraine attacks per month … , 1 while others suggest it for those who experience a headache on most days of the month. 10, 11, … a headache diary to record information on pain and associated symptoms day by day for at least 1 month … On ≥8 days per month for at least 3 months headache has fulfilled C.1 and/or C.2 below, that is, has

67. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: 2023 Update -- Surveillance Report 2 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-update-surv-rep-2.pdf
    January 01, 2023 - New studies identified since the 2023 systematic review Month (search end date) Citation Risk

68. Cancer Quality-ASSIST Supportive Oncology Quality Indicator Set: Feasibility, Reliability, and Validity Testing (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
    April 01, 2010 - reliable IF a patient is diagnosed with cancer, THEN s/he should be screened for depression within 1 month … assessment IF a patient with cancer has new fatigue, THEN there should be an assessment within 1 month … exam, THEN a discussion including prognosis and advance care planning should be documented within 1 month … they should be offered symptomatic management or treatment directed at an underlying cause within one month … factor receptors (EGFR), then the presence and severity of skin rash should be evaluated within 1 month

69. Linking Dental Services to Treatment Outcomes for Diabetes: A Rapid Response Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/treatment-outcomes-diabetes-rapid-research.pdf
    November 01, 2024 - Over a 12-month period, patients received gingivitis treatment, including supra-gingival scaling and … MD = -0.43, p < 0.00001 [30 studies]; 6-month MD = -0.30, p = 0.007 [11 studies]). … : -0.65, 95%CI [-0.97, -0.32]; p = 0.000; NSPT 6 month: −0.29%; 95% CI [−0.56, −0.02], p=0.033; NSPT … +ABX: 3 month: -1.17%, 95%CI [-1.64, -0.71]; p=0.011; 66.30% Elnour 202332; Very Low; High; NR; … : ns 6-month: -1.9, 95%CI [-3.05, -0.74], p = 0.001 3-month: 57% 6-month: 98% Obadan-Udoh 201730

70. Arthritis and Nontraumatic Joint Disease (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-13121.pdf
    December 05, 2013 - In August 2013, FDA approved Mobi-C for single-level cervical disc replacement and later that month … (n=12) and 12-month (n=10) followup. … and Numeric Rating Scale scores were observed in patients who received PRP injections at 3- and 6-month … better than at baseline (p<0.0005).66 By 24-month followup, all evaluated outcomes were significantly … lower than those observed at 12-month followup.

71. Behavioral Programs for Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
    September 11, 2015 - and analyzed data from different postintervention followup timepoints: end of intervention to ≤1 month … postintervention, >1 month to ≤6 months, >6 months to ≤12 months, >12 months to ≤24 months, and … diabetes self- management >12m followup 1 (390); SMBG 1 (190); skipping 1 or more doses in past month … Self-Management Profile (scale not reported; higher scores better); EOI = end of intervention to ≤1 month … (interventions 1.5–25 months); HbA1c = hemoglobin A1c; HRQL = health-related quality of life; m = month

72. Antibody Response Following SARS-CoV-2 Infection and Implications for Immunity: Final Update of a Rapid, Living Review (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-3-immunity-after-COVID-19.pdf
    December 31, 2022 - ^ 27/41 (66%) — 3 months^ 21/31 (68%) — 6 months^ 16/18 (89%) — 1 month^ 17/18 (94%) — 3 months^ … 16/17 (94%) — 6 months^ IgG anti-N 36/45 (80%) — 1 month^ 32/41 (78%) — 3 months^ 19/31 (61%) — … 6 months^ 18/18 (100%) — 1 month^ NR/NR (89%) — 3 months^ NR/NR (65%) — 6 months^ Marra, 2020 … 22/42 (52%) — 3 months 14/41 (34%) — 6 months 6/20 (30%) — 9 months 20/23 (87%) — 1 month 48/55 … (87%) — 3 months 17/29 (59%) — 6 months 20/41 (49%) — 9 months IgG anti-S 21/22 (96%) — 1 month

73. Ptsd-Adults-Trauma-Interventions Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adults-trauma-interventions_executive.pdf
    April 01, 2013 - had insufficient data (single study) to determine the efficacy of debriefing at 2- or 6-week or 11-month … CBT with SC in a sample of participants with ASD found that at both the end of treatment and at 6-month … However, at both the end of treatment and at 6-month followup, CBT was no more effective than SC for … , 9-month, and 12-month followup (low SOE, one RCT) … Twelve-month prevalence of DSM-IV/WMH-CIDI disorders by sex and cohort. 2007. www.hcp.med.harvard.edu

74. Behavioral Interventions for Migraine Prevention (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/bimp-protocol.pdf
    September 27, 2022 - All KQs 7 Migraine/Headache frequency: • Migraine / headache count: Migraine days per month … , migraine attacks per month, headache days per month, or headaches per month … thresholds for powering trials, for headache frequency, we will use a difference of 1 migraine day/month … the SOE for the following outcomes: • Migraine/Headache Frequency (most often reported in days per month

75. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
    January 09, 2020 - MOH is operationally defined based on headache frequency (15 or more days per month for greater than … 3 months) and days of use per month of specific medications.8 Triptans, ergots alkaloids, combination … analgesics, or opioids on 10 or more days per month meets criteria for medication overuse. … including 2 nonsteroidal anti-inflammatory drugs (NSAIDs) used on 15 or more days per month … of more than one class of medications, for example a triptan and an NSAID, on 10 or more days per month

76. Diabetes Mellitus (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
    January 01, 2016 - pharmacies range from about $400 to $415 per month or about $4,800 per year, all with the use of a … HbA1c is a measure of the average amount of glucose in a patient’s blood over a 3- or 4- month period … pharmacies ranged from about $400 to $415 per month or about $4,800 per year, all with the use of a … The incidence of incisional glaucoma surgery at month 36 was 4.8% in the low- dose group and 8.1% in … The 36-month trial results were provided to FDA in May 2011.

77. Psychological and Pharmacological Treatments for Adults with Posttraumatic (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-adult-treatment-update_research-protocol.pdf
    December 31, 2017 - 87.5%) of adults exposed to one or more potentially traumatic events meet criteria for PTSD within 1 month … Criterion F: Duration of disturbance • Duration of disturbance symptoms is more than 1 month … Clinically significant distress or impairment • Duration of disturbance symptoms is more than 1 month … Clinically significant distress or impairment • Duration of disturbance symptoms is more than 1 month … • Past week, past month, and worst month (lifetime) PTSD can be estimated.

78. Angina-Heart-Attack-Treatments Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
    January 01, 2014 - therapy and 6- and 24-month therapy; 1 observational study showed that discontinuation before 6 … (1 RCT; 2,013 patients) Insufficient evidence due to imprecision: no difference between 6- and 24-month … (1 RCT; 1,443 patients) Insufficient evidence due to imprecision: no difference between 6- and 12-month … treatment; the other 2 RCTs (1 month vs. 12 months and 6 months vs. 12 months) showed no statistically … A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month

79. Data Points 14: Use of Endocrine Therapy (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dcis-endocrine-therapy_research.pdf
    August 01, 2012 - cancer in each cohort, 2007-2008* Months since diagnosis Total 0-12 13-24 25-36 37-48 49-60 Diagnosis Month … based on the presence of an HMO Indicator (gho1-gho288) not equal to “0” or “4” for at least one month … Eligible Status Code monthly indicator (plan07_01 – plan08_12) between “01” and “09” for at least one month … examine in this report consists of 6,252 women diagnosed with DCIS (approximately 1,200-1,300 in each month … grouping) and 27,378 diagnosed with early invasive breast cancer (between 5,000 and 6,000 in each month

80. Cer-251-Integrated-Pain-Management-App-F (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-251-integrated-pain-management-app-F.xlsx
    January 01, 2020 - Appendix F Appendix F. Risk of Bias Assessments Table F-1. IPMP RCTs Table F-1. Risk of bias assessments for randomized controlled trials evaluating integrated pain management programs (IPMPs) Author, Year Randomization Adequate? Allocation Concealment Adequate? Groups Similar at Baseline? …